AF
TYRA icon

Amalgamated Financial’s Tyra Biosciences TYRA Stock Holding History

Amalgamated Financial’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$19K Buy
+1,771
New +$21K ﹤0.01% 2763

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Amalgamated Financial's TYRA Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Tyra Biosciences (TYRA) in Q1 2022: 1,771 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #2763 among its holdings.

46 funds tracked by Wall St. Rank hold TYRA as of Q1 2022.

  • Amalgamated Financial held 1,771 shares of Tyra Biosciences worth $19K as of Q1 2022.
  • Tyra Biosciences was a new Amalgamated Financial position in Q1 2022.
  • Tyra Biosciences made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2763 holding.
  • 46 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.